Insilico and Lilly enter $100 M research and licensing collaboration to advance AI-driven drug discovery

Singapore, Nov. 11 -- Hong Kong-based Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has announced a research collaboration with Eli Lilly t... Read More

• ««
• «
• 14
• 15
• 16
• 17
• 18
• 19